持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/09/09 | 日証協 | 131,234株 | +12.38% | 24,600株 | -52.94% | 98,127株 | +1.55% | 54,227株 | -18.33% |
2022/09/02 | 日証協 | 116,775株 | -26.24% | 52,276株 | -67.13% | 96,627株 | -5.49% | 66,394株 | -27.11% |
2022/08/26 | 日証協 | 158,325株 | +15.14% | 159,056株 | +410.51% | 102,240株 | +49.76% | 91,090株 | +419.83% |
2022/08/19 | 日証協 | 137,512株 | -4.98% | 31,156株 | +55.45% | 68,267株 | -4.07% | 17,523株 | +4.8% |
2022/08/12 | 日証協 | 144,712株 | +3.73% | 20,043株 | -50.47% | 71,164株 | +11.47% | 16,720株 | -23.52% |
2022/08/05 | 日証協 | 139,512株 | -12.66% | 40,463株 | -67.17% | 63,843株 | -25.73% | 21,861株 | -17.88% |
2022/07/29 | 日証協 | 159,735株 | +102.56% | 123,268株 | +322.15% | 85,958株 | +13.61% | 26,620株 | +21.44% |
2022/07/22 | 日証協 | 78,858株 | -2.88% | 29,200株 | +179.69% | 75,658株 | -7.61% | 21,920株 | -15.73% |
2022/07/15 | 日証協 | 81,198株 | +1.77% | 10,440株 | -58.9% | 81,894株 | -6.51% | 26,012株 | +59.64% |
2022/07/08 | 日証協 | 79,784株 | -27.06% | 25,400株 | -58.22% | 87,594株 | -20.1% | 16,294株 | -19.6% |
2022/07/01 | 日証協 | 109,384株 | -5.16% | 60,800株 | -29.35% | 109,632株 | +2.89% | 20,265株 | -35.53% |
2022/06/24 | 日証協 | 115,336株 | +24.61% | 86,052株 | +694.5% | 106,554株 | +14.75% | 31,432株 | +50.88% |
2022/06/17 | 日証協 | 92,555株 | -37.84% | 10,831株 | -56.83% | 92,854株 | -12.8% | 20,832株 | +62.75% |
2022/06/10 | 日証協 | 148,904株 | +2.62% | 25,091株 | -86.48% | 106,488株 | -3.54% | 12,800株 | -70.57% |
2022/06/03 | 日証協 | 145,107株 | -38.75% | 185,630株 | -66.52% | 110,391株 | -47.38% | 43,500株 | -24.22% |
2022/05/27 | 日証協 | 236,904株 | +24.28% | 554,451株 | +69.85% | 209,788株 | +28.24% | 57,400株 | -31.7% |
2022/05/20 | 日証協 | 190,624株 | +53.39% | 326,434株 | +1185.02% | 163,588株 | +55.43% | 84,041株 | +517.95% |
2022/05/13 | 日証協 | 124,271株 | +6.7% | 25,403株 | -11.62% | 105,247株 | +10.85% | 13,600株 | +156.6% |
2022/05/06 | 日証協 | 116,471株 | -0.64% | 28,743株 | -74.65% | 94,947株 | -12.77% | 5,300株 | -74.02% |
※株式分割は考慮していませんのでご注意ください。
Page Top